Drug Profile
Elcometrine/estradiol - Population Council/Therapeutics MD
Alternative Names: Annovera; Elcometrine/estradiol ATD™ gel; Estradiol/elcometrine transdermal gel - Antares Pharma/Population Council; Estradiol/elcometrine vaginal ring; NES-E2 CVR; NES/E2; NES/EE/CVR; Nestorone®/estradiol; NestraGel; Ringza; Segesterone acetate and ethinyl estradiol vaginal system; Segesterone acetate/ethinyl estradiol vaginal ring; Segesterone acetate/ethinyl estradiol vaginal systemLatest Information Update: 05 Dec 2023
Price :
$50
*
At a glance
- Originator Antares Pharma; Population Council (USA)
- Developer Antares Pharma; Duchesnay Inc; Population Council (USA); TherapeuticsMD
- Class Estradiol congeners; Estrenes; Hormonal contraceptives; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Pregnancy